DrugPatentWatch Database Preview
Litigation Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
Docket | Start Trial | Date Filed | 2015-03-23 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Mary Little Cooper |
Jury Demand | None | Referred To | Douglas E. Arpert |
Parties | EMCURE PHARMACEUTICALS USA, INC.; EMCURE PHARMACEUTICALS LIMITED; EXELA HOLDINGS, INC.; EXELA PHARMA SCIENCES, LLC; EXELA PHARMSCI, INC.; FRESENIUS KABI USA, LLC; HELSINN HEALTHCARE S.A.; HOSPIRA WORLDWIDE, INC.; HOSPIRA, INC.; ROCHE PALO ALTO LLC | ||
Patents | 5,854,270; 5,955,488; 6,063,802; 6,132,758; 6,284,770; 6,294,548; 7,947,724; 7,947,725; 7,960,424; 8,518,981; 8,598,219; 8,729,094 | ||
Attorneys | ALLISON LINDA HOLLOWS; ANGELA CHERYL NI; ARNOLD B. CALMANN; CHARLES MICHAEL LIZZA; DAVID C. KISTLER; ERIC W. DITTMANN; GARY J. RUCKELSHAUS; ISAAC SAMUEL ASHKENAZI; JEFFREY S. SOOS; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; LEE A. GOLDBERG; SARAH ANN SULLIVAN; STEVEN JAMES LINK; WILLIAM C. BATON | ||
Firms | Blank Rome LLP; Fox Rothschild LLP; Fox Rothschild LLP, Pc; Heritage Pharmaceuticals Inc.; Merchant & Gould Pc | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in HELSINN HEALTHCARE S.A. v. HOSPIRA, INC.
Details for HELSINN HEALTHCARE S.A. v. HOSPIRA, INC. (D.N.J. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-03-23 | 1 | 5,854,270 A * 12/1998 Gambhir . … for reducing chemotherapy and radio- 5,854,270 A 12/1998 Gambhir …Collin ........................... 424/489 5,854,270 A 12/1998 Gambhir … 5,854,270 A 1211998 Gambhir (72) Inventors…, the ’724 patent, the ’725 patent, the ’424 patent, the ’219 patent, and the ’094 patent are listed | External link to document | |
2016-04-05 | 86 | United States Patent No. 7,947,724 (“the ‘724 patent”), No. 7,947,725 (“the ‘725 patent”), No. 7,960,…“the ‘424 patent”), No. 8,598,219 (“the ‘219 patent”), and No. 8,729,094 (“the ‘094 patent”) (collectively…other assignee of the Aloxi® patents. (See dkt. 22 at 6.) The Aloxi® patents claim various formulations…Aloxi® patents; (2) Defendants’ paragraph IV notice letter allegations that the Aloxi® patents are invalid…(b) of the Patent Act provides that: “Whoever actively induces infringement of a patent shall be liable | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |